FDA要求将减肥药Belviq XR (lorcaserin)撤出市场
2020.02.13
FDA Requests Voluntary Withdrawal of Weight-Loss Medication After Clinical Trial Shows an Increased Occurrence of Cancer
在临床试验表明癌症发病率增加后FDA要求自愿撤回减肥药
The following quote is attributed to Janet Woodcock, M.D., director of the ...
|